• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于GeneReader NGS测序平台检测到的突变及其敏感性的详细概述。

Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform.

作者信息

Lüsebrink Jessica, Pieper Monika, Tillmann Ramona-Liza, Brockmann Michael, Schildgen Oliver, Schildgen Verena

机构信息

Kliniken der Stadt Köln gGmbH, Klinikum der Privaten Universität Witten/Herdecke mit Sitz in Köln, Institut für Pathologie, Ostmerheimer Str. 200, D-51109 Köln/Cologne, Germany.

出版信息

Data Brief. 2018 May 4;18:1962-1966. doi: 10.1016/j.dib.2018.04.114. eCollection 2018 Jun.

DOI:10.1016/j.dib.2018.04.114
PMID:29904702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5998651/
Abstract

This article presents additional next generation data from our pre-clinical validation study. In total 121 samples (clinical specimen and interlaboratory test samples) were tested successfully with next generation sequencing. 38 different mutations in six different genes were detected. Next to the detection of different mutations, the reproducibility of the NGS test was analyzed. Three samples were analyzed five times and the results were compared. Several mutations classified as non-pathogenic so far, have been detected repeatedly.

摘要

本文展示了我们临床前验证研究的更多下一代数据。总共121个样本(临床标本和实验室间测试样本)通过下一代测序成功进行了检测。在六个不同基因中检测到38种不同的突变。除了检测不同的突变外,还分析了NGS测试的可重复性。对三个样本进行了五次分析并比较了结果。迄今被归类为非致病性的几种突变已被重复检测到。

相似文献

1
Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform.关于GeneReader NGS测序平台检测到的突变及其敏感性的详细概述。
Data Brief. 2018 May 4;18:1962-1966. doi: 10.1016/j.dib.2018.04.114. eCollection 2018 Jun.
2
Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.使用QIAGEN GeneReader NGS系统检测KRAS突变,该系统已通过QIAGEN Therascreen PCR试剂盒和替代NGS平台验证。
BMC Cancer. 2017 May 22;17(1):358. doi: 10.1186/s12885-017-3328-z.
3
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.Ion PGM和GeneReader NGS系统在晚期肺腺癌患者日常临床实践中的应用:基于90例患者比较研究与评估的实践观点
Cancers (Basel). 2018 Mar 21;10(4):88. doi: 10.3390/cancers10040088.
4
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.基于癌症基因Panel 的新一代测序在转化研究和分子诊断中的多中心验证。
Virchows Arch. 2018 Apr;472(4):557-565. doi: 10.1007/s00428-017-2288-7. Epub 2018 Jan 27.
5
Pre-clinical validation of a next generation sequencing testing panel.下一代测序检测面板的临床前验证。
Exp Mol Pathol. 2018 Jun;104(3):170-174. doi: 10.1016/j.yexmp.2018.04.001. Epub 2018 Apr 8.
6
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.使用下一代测序(NGS)平台从存档肿瘤标本中诊断致病性种系 BRCA1/2 突变。
Gynecol Oncol. 2019 Nov;155(2):275-279. doi: 10.1016/j.ygyno.2019.08.027. Epub 2019 Aug 31.
7
Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.采用全自动平台直接 DNA 移液和下一代测序进行实验室工作流程优化,评估转移性结直肠癌患者 KRAS、NRAS 和 BRAF 热点突变检测。
PLoS One. 2019 Jul 2;14(7):e0219204. doi: 10.1371/journal.pone.0219204. eCollection 2019.
8
Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.在青少年成年起病型糖尿病患者中使用靶向新一代测序技术进行单基因糖尿病的基因检测。
Pol Arch Med Wewn. 2015;125(11):845-51. doi: 10.20452/pamw.3164. Epub 2015 Nov 9.
9
Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.在常规实验室实践中实施下一代测序技术进行体细胞突变检测。
Pathology. 2018 Jun;50(4):389-401. doi: 10.1016/j.pathol.2018.01.005. Epub 2018 May 8.
10
Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.下一代测序技术在肺癌支气管内超声引导经支气管针吸活检样本基因分型中的应用。
Ann Thorac Surg. 2019 Jul;108(1):219-226. doi: 10.1016/j.athoracsur.2019.02.010. Epub 2019 Mar 15.

引用本文的文献

1
Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models.CK-MB-1曲妥珠单抗耐药HER2阳性乳腺癌细胞系及异种移植动物模型的建立。
Cancer Med. 2021 Apr;10(7):2370-2379. doi: 10.1002/cam4.3824. Epub 2021 Mar 5.
2
Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs.在接受 TKI 治疗前的 NSCLC 中通过 NGS 检测到共同发生的基因改变和原发性 EGFR T790M 突变。
J Cancer Res Clin Oncol. 2020 Feb;146(2):407-416. doi: 10.1007/s00432-019-03065-0. Epub 2019 Nov 6.
3
NGS-dataset of putative driver mutations associated with benign peritoneal strumosis.与良性腹膜甲状腺肿相关的假定驱动突变的二代测序数据集
Data Brief. 2018 Aug 16;20:468-470. doi: 10.1016/j.dib.2018.08.006. eCollection 2018 Oct.

本文引用的文献

1
Pre-clinical validation of a next generation sequencing testing panel.下一代测序检测面板的临床前验证。
Exp Mol Pathol. 2018 Jun;104(3):170-174. doi: 10.1016/j.yexmp.2018.04.001. Epub 2018 Apr 8.